SCHEMBL5200342

SCHEMBL5200342

CC(C)(C)N1C(=O)C(NC2CCN(c3ncc(C(F)(F)F)cc3Cl)CC2)=C(c2ccccc2)S1(=O)=O.CC(C)(C)N1C(=O)C(NCCOc2ccccc2OS(C)(=O)=O)=C(c2ccccc2)S1(=O)=O.CC(C)(C)OC(=O)N1CC(CCNC2=C(c3ccccc3)S(=O)(=O)N(C(C)(C)C)C2=O)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 5/20 0.40
CHRM1 P11229 3/20 0.40
CHRM3 P20309 3/20 0.40
CHRM5 P08912 2/20 0.40
CYP2C9 P11712 3/20 0.37
CYP2C19 P33261 3/20 0.37
MAPT P10636 3/20 0.37
GAA P10253 1/20 0.37
KDM4E B2RXH2 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 2/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
CHRM2 P08172 2/20 0.34
METAP1 P53582 1/20 0.33
CXCR3 P49682 1/20 0.33
SLC6A9 P48067 1/20 0.33
KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5200341 0.97 CHRM4 (0.39) CHRM4CHRM1CHRM3CHRM5CYP2C9
SCHEMBL1995171 0.78 METAP1 (0.49) CHRM4CHRM1CHRM3CHRM5CYP2C9
SCHEMBL2006147 0.74 NAMPT (0.44) KDM4E
SCHEMBL1999833 0.72 NR1H2 (0.43) GAAKDM4EALDH1A1
SCHEMBL2001035 0.69 NR1H2 (0.48) MAPTKDM4EALDH1A1
SCHEMBL1996472 0.69 METAP1 (0.49) CHRM4CHRM1CHRM3CHRM5CYP2C9
SCHEMBL1996471 0.68 NR1H2 (0.43) KDM4E
SCHEMBL2006144 0.67 NAMPT (0.44) KDM4E
SCHEMBL1997004 0.67 NR1H2 (0.41) HPGD
SCHEMBL2003962 0.67 HCRTR1 (0.47) CHRM4CHRM1MAPTGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1838687-A1 NON-ANILINIC DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS AstraZeneca AB (SE) 2007-10-03 EP disclosed
WO-2006073366-A1 NON-ANILINIC DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2006-07-13 WO disclosed